Latest filing published 16 Sept 2024 for Isofol Medical AB, €8,005.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Magnus Hurst: trading record in brief
Magnus Hurst discloses dealings in Isofol Medical AB to Finansinspektionen. Between 11 January 2024 and 13 September 2024, the trades on record add up to 2 filings.
On the open market, the record shows 1 purchase worth €2,152 and 1 sale worth €8,005. On balance, insiders were net sellers of €5,853. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 16 September 2024, reports an open-market sale of €8,005 in Isofol Medical AB. The last insider purchase was made public on 11 January 2024, 1,032 days ago. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Magnus Hurst
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,500 shares@ SEK 2.5778.8% of flowAktieISIN SE0009581051FI:csv-d0f0f40ef723e8f173a7
- 35,000 shares@ SEK 0.6921.2% of flowAktieISIN SE0009581051FI:csv-4be3e7e059f789f1dcb6Canonical exit: 10 Apr 2024 (T+90)
2 of 2 declarations